You are here

Biocat

CRAASH Barcelona able exoesquelet
23.03.2018

35 projects, 70% from the BioRegion, applied to the acceleration program promoted by Biocat and CIMIT (Boston)

Claus per Bioemprendre Biocat curs bioemprenedoria emprenedors
27.03.2018

Top bioentrepreneurship in Catalonia will share their personal experiences with students and researchers on 15, 22 and 29 May

wild card biocat eit health
12.03.2018

The finalists will face off from April 16 to 20 in Galway in a tournament to choose the members of two teams that will receive €2 million each

Aceleradora enfermedades raras AMMIC RIS3CAT Biocat
05.03.2018

Acceleradora en Malalties Minoritàries de Catalunya (AMMIC) is part of the RIS3CAT community coordinated by Biocat. It is led by IUCT and other members include VHIR, Esteve, Aromics, BCN Peptides, Minoryx, Aniling and Qgenomics

start.smart.japan
19.02.2018

The Start.Smart.Japan program includes a week of training in Munich on the barriers to the Japanese market and a mission to BioJapan

14.02.2018

Barcelona, February 14, 2018. - Biocat is bringing the CRAASH Barcelona acceleration program to Europe. This 12-week course will help research teams from Catalonia and other European countries successfully launch innovation to market in the medical devices, diagnostics, e-health and digital health arena.

The program will select and train eight research teams to commercialize their technology within 3 to 5 years. Participants will be guided by expert mentors from CIMIT (...

Claus per Bioemprendre Banner
25.01.2018

Las empresas interesadas pueden solicitar 'vouchers': la próxima fecha de corte es el 31 de marzo

Toronto
26.02.2018

It is the second most interesting overseas market for the future for Catalan firms according to 2017 Internationalization Survey 

18.01.2018

This European alliance co-organized by Biocat is geared towards the markets in the USA, Canada, Japan, South Korea, Australia, Israel, New Zealand and Singapore

BIO Europe Spring 2017
20.12.2017

Cutting-edge studies in the best international scientific publications, rounds of investment, licenses… despite saying goodbye to the EMA and the political instability of this last quarter of the year, the Catalan healthcare and life sciences sector has maintained its role as a global benchmark for this type of ecosystem.